<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Surgery: Transplantation Topic Collection</title>
    <link>http://archsurg.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Wed, 17 Apr 2013 00:00:00 GMT</pubDate>
    <lastBuildDate>Wed, 17 Apr 2013 22:54:15 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archsurg.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archsurg.jamanetwork.com</webMaster>
    <item>
      <title>Low Rates of Short- and Long-term Graft Loss After Kidney-Pancreas Transplant From a Single Center Low Graft Loss Rates in Kidney-Pancreas Transplant </title>
      <link>http://archsurg.jamanetwork.com/article.aspx?articleID=1679647</link>
      <pubDate>Mon, 01 Apr 2013 00:00:00 GMT</pubDate>
      <author>Tai DS, Hong J, Busuttil RW, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Importance&lt;/div&gt;Since the 1980s, pancreas transplant has become the most effective treatment strategy to restore euglycemia in patients with type 1 diabetes mellitus. However, technical complications and BK virus nephropathy continue to be important causes of early and late graft loss. These and other complications lead to cited 1- and 3-year graft survival rates of 74% and 67% (pancreas) and 81% and 73% (kidney).&lt;div class="boxTitle"&gt;Objective&lt;/div&gt;To examine our center's outcomes with pancreas-kidney transplant and early BK virus screening and treatment.&lt;div class="boxTitle"&gt;Design&lt;/div&gt;Prospective study from August 2004 to January 2012.&lt;div class="boxTitle"&gt;Setting&lt;/div&gt;University medical center.&lt;div class="boxTitle"&gt;Participants&lt;/div&gt;Sixty-five patients with type 1 diabetes who underwent simultaneous kidney and pancreas, pancreas after kidney, or pancreas transplant alone at a single center.&lt;div class="boxTitle"&gt;Intervention&lt;/div&gt;Pancreas transplant.&lt;div class="boxTitle"&gt;Main Outcome Measures&lt;/div&gt;Pancreas and kidney survival; patient survival; and kidney loss due to BK virus nephropathy.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;Patient survival at 1, 3, and 5 years was 100%, 98.4%, and 98.4%, respectively. Of 2 early pancreatic allograft losses, 1 was due to thrombosis (1.6%). One- and 5-year pancreas graft survival rates were 95.4% and 92.3%; losses after more than 1 year were due to rejection. Kidney survival rates were 100% and 95.2% at 1 and 5 years; losses were due to nephropathy and noncompliance, with 1 death with function. BK virus incidence was 29.2%, with no graft losses due to BK infection.&lt;div class="boxTitle"&gt;Conclusions and Relevance&lt;/div&gt;While pancreas transplant can be complicated by early graft loss, our results suggest that excellent outcomes at 5 years can be achieved. Posttransplant BK virus screening and treatment are essential tools to long-term success.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">148</prism:volume>
      <prism:number xmlns:prism="prism">4</prism:number>
      <prism:startingPage xmlns:prism="prism">368</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">373</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/2013.jamasurg.261</prism:doi>
      <guid>http://archsurg.jamanetwork.com/article.aspx?articleID=1679647</guid>
    </item>
  </channel>
</rss>